Influenza A virus HA/Hemagglutinin protein (Recombinant-Active) (C-His) (STJP011704)
SPECIFICATIONS
HostMammalian Cells
ConjugationUnconjugated
ImmunogenInfluenza A virus (A/canine/Guangdong/1/2006 (H3N2) )
General Information
| Short Description | Recombinant-Active-Influenza A virus HA/Hemagglutinin-C-His protein was developed from mammalian cells and has a target region of C-His. For use in research applications. |
| Applications | ELISA/WB |
| Host | Mammalian Cells |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Dilution Range | Reconstitute in sterile water for a stock solution. |
| Formulation | Lyophilized from a solution in PBS pH 7.4, 5% Trehalose, 5% Mannitol. |
| Storage Instruction | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at-20 to-80°C for twelve months from the date of receipt. |
| Endotoxin | <0.1 EU/Mu g of the protein by the LAL method. |
| Immunoreactivity | Measured by its binding ability in a functional ELISA. When recombinant human Galectin-1 Immobilised at 10.00 Mu g/mL, 100 Mu L/well, the concentration of recombinant Influenza A Virus (H3N2) HA/Hemagglutinin that produces 50% of the optimal binding |
Target Information
| Immunogen | Influenza A virus (A/canine/Guangdong/1/2006 (H3N2) ) |
| Immunogen Region | Gln17-Trp530 |